Drug ads sell a problem, not a solution
By Jonathan Rowe | Christian Science Monitor | August 21, 2006
It is an old saying in the advertising trade that you sell the problem, not the
solution. That helps explain why the media today are awash with images of disease.
Erectile dysfunction, depression, stress, attention deficit disorder, on and on
- you can't escape them and the sense of looming peril that they conjure up.
Politicians sell terror and fear; pharmaceutical companies sell disease. Every
state and stage of existence has become a pathology in need of pharmaceutical
"intervention," and life itself is a petri dish of biochemical deficiency
and need. Shyness is now "social anxiety disorder." A twitchy tendency
has become "restless leg syndrome." Three decades ago the head of Merck
dreamed aloud of the day when the definition of disease would be so broad that
his company could "sell to everyone," like chewing gum.
That day is rapidly approaching, if it's not already here. "We're increasingly
turning normal people into patients," said Dr. Lisa M. Schwartz of the Dartmouth
Medical School. "The ordinary experiences of life become a diagnosis, which
makes healthy people feel like they're sick."
In one sense, the ads have been successful. The Kaiser Family Foundation found
that every dollar drug companies spend on ads brings more than four dollars in
additional sales. But for most others, the result has been soaring medical insurance
costs, toxic side effects, and new tensions between doctors and patients, who
increasingly badger doctors for the drugs they've seen on TV.
One study found that 30 percent of Americans have made these demands. A Minnesota
doctor complained recently that patients now push him for sleep medications "when
maybe they just need to go to bed on a more regular basis."
But perhaps the worst part is that prescription drug ads have immersed us all
in a pervasive drug culture that seems to have no boundaries. We are being reduced
to helpless "consumers" who have no capacity to deal with challenges
other than by taking a pill. Last month Tim Pawlenty, the Republican governor
of Minnesota, called for a moratorium on prescription drug ads. It's about time.
For most of the past half century, there were tight restrictions on the general
advertising of prescription drugs. These require doctors' guidance for a reason;
so why should Madison Avenue get involved? But under heavy pressure from the drug
and advertising industries, the government backed down in the late 1990s, and
that started the tsunami.
Spending on drug ads for the general public more than tripled between 1996 and
2001. It is now some $4 billion a year, which is more than twice what McDonald's
spends on ads. In 1994, the typical American had seven prescriptions a year, which
is no small number. By 2004, that was up to 12 a year. Homebuilders are touting
medicine cabinets that are "triple-wide."
The industry says this is all about "educating" the consumer. But an
ad executive was more candid when he said - boasted, really - that the goal is
to "drive patients to their doctors." Reuters Business Insight, a publication
for investors, explained that the future of the industry depends on its ability
to "create new disease markets." "The coming years," it said,
"will bear greater witness to the corporate-sponsored creation of disease."
The Kaiser study found that drug ads increase sales for entire categories of drugs,
not just the one in question. The ads really are selling the disease more than
a cure.
Advertising is just one way the industry has sought to accomplish this goal. It
also funds patient advocacy groups such as Children With Attention Deficit Disorder
(CHADD), and doctors who push for expanded definitions of disease, among a host
of other things. (When the definition of ADD expanded in the 1980s, the number
of kids tagged with this problem increased by 50 percent.)
But advertising is the most pervasive and aggressive way of selling sickness.
It also is the hardest to justify. Medicine is supposed to be about science, not
huckstering; about healing people, not persuading more of them that they are sick.
There are far better ways to inform the public about health issues than to spend
billions of dollars a year pushing pills.
This is why more than 200 medical school professors recently called for an end
to prescription drug ads, and why close to 40 health and seniors groups have joined
them. Even the American Medical Association, many members of which have close
ties to the pharmaceutical industry, has urged restrictions. Washington should
listen to these doctors. As Governor Pawlenty put it, we need to put "the
decisionmaking back where it should be - on an informed basis between the patient
and the doctor."
Jonathan Rowe is issues director at Commercial Alert and a fellow
at the Tomales Bay Institute, Point Reyes Station, CA. He is a former Monitor
staff writer.
Copyright © 2006 The Christian Science Monitor.
Back to: Scare-and-Sell ads
| The Pitch | Home